Fluorodeoxyglucose News and Research

RSS

Metal-containing radiopharmaceuticals could improve access to diagnostic imaging of AD

A team of researchers from the Laboratory of Biophysics at NUST MISIS, Lomonosov Moscow State University and D. Mendeleev University of Chemical Technology of Russia has summarized metal-containing diagnostic agents for positron emission tomography (PET), magnetic resonance imaging (MRI), and single-photon emission computed tomography (SPECT) imaging of Alzheimer's disease (AD).

9 Feb 2021

Whole body imaging detects more myeloma-defining disease, allows treatment to be initiated earlier

Researchers from King's College London have shown that whole body magnetic resonance imaging (WBMRI) not only detects more myeloma-defining disease than positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) but that it also allows critical treatment to be initiated earlier.

21 Jan 2021

Brain metabolic changes associated with loss of smell in COVID-19

A recent study detailed in a preprint paper published in medRxiv, researchers from Belgium, discuss how they investigated possible central nervous system (CNS) involvement in COVID-19 patients with a sudden loss of smell using a hybrid positron emission tomography (PET)-magnetic resonance imaging (MRI) system (PET-MR).

21 Oct 2020

New tool can provide non-invasive decision support for NSCLC treatment

Personalized treatment options for patients with lung cancer have come a long way in the past two decades.

16 Oct 2020

Researchers confirm safety of cancer-specific PET probe in first-in-human clinical studies

A group of researchers led by Assistant Professor WATABE Tadashi of the Graduate School of Medicine of Osaka University achieved the stable domestic production of automatic synthesis modules for positron emission tomography (PET) probe F-18 NKO-035, a LAT1-selective amino acid derivative radiolabeled with 18F, confirming its safety in first-in-human clinical studies conducted at Osaka University Hospital in November 2019.

22 Jan 2020

Amyloid PET scan is not an effective method for measuring severity, progression of Alzheimer's

While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer's disease, giving patients an amyloid PET scan is not an effective method for measuring their cognitive function, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania and Thomas Jefferson University.

6 Aug 2019

Higher levels of physical activity not linked to greater volume or activity of brown adipose tissue

A study conducted by researchers from the University of Granada has found that, in contrast to scientific thinking to date, higher levels of physical activity are not linked to a greater volume or activity of brown adipose tissue.

5 Jul 2019

ALS mobility and survival could be improved by increasing glucose

Researchers from University of Arizona have come up with a new study that shows that increasing the amount of glucose that could be transformed into energy could help persons with amyotrophic lateral sclerosis (ALS) by improving their mobility and increasing their survival rates.

26 Jun 2019

AI could help spot Alzheimer’s early finds study

Artificial intelligence (AI) may soon be used to detect Alzheimer’s disease early in the course of disease say researchers. The results of the study were published in the latest issue of the journal Radiology.

8 Nov 2018

New nuclear medicine imaging method could help diagnose widespread tumors

A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.

6 Sep 2018

Phototherapeutic technology shows potential as anti-cancer weapon

A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy -; which is limited to the skin and areas accessible with an endoscope -; this technique can target and attack cancer cells that have spread deep inside the body, according to researchers at Washington University School of Medicine in St. Louis.

25 Jan 2018

FDG PET/CT imaging shows correlation between amount of cfDNA and cancer aggressiveness

Italian researchers have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC).

7 Nov 2017

Hypometabolism in medial prefrontal areas linked to AD-related nutritional problems

A new study from the Multimodal Neuroimaging for AD Diagnosis study, which is a prospective study implemented at the National Center for Geriatrics and Gerontology, provides that hypometabolism in the medial prefrontal areas is specifically associated with Alzheimer's disease-related nutritional problems, and decrease in fat mass may have a key role. This study is published in the Journal of Alzheimer's Disease.

15 Sep 2017

Combined PET/CT scanning could identify melanoma patients' response to ICI therapy

Advanced melanoma, a type of skin cancer that has spread to other areas of the body, has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined positron emission tomography/computed tomography (PET/CT) scanning early in treatment could identify whether the therapy will benefit a particular patient.

6 Sep 2017

Moderate physical activity linked to healthy glucose metabolism in the brain

People at risk for Alzheimer's disease who do more moderate-intensity physical activity, but not light-intensity physical activity, are more likely to have healthy patterns of glucose metabolism in their brain, according to a new UW-Madison study.

22 Jun 2017

Hybrid molecular imaging system detects vulnerable arterial plaques in earliest stages

A new study shows that a hybrid molecular imaging system unites three imaging modalities to map the composition of dangerous arterial plaques before they rupture and induce a major cardiac event.

12 Jun 2017

Researchers uncover novel and non-invasive way to track dengue infection

Commonly used to detect solid tumors, positron emission tomography (PET) paired with the glucose metabolism probe, fluorodeoxyglucose (FDG), is considered 'old' technology in the field of cancer.

6 Jun 2017

CLI could be promising technique for assessing tumor margins during breast-conserving surgery

Breast-conserving surgery is the primary treatment for early-stage breast cancer, but more accurate techniques are needed to assess resection margins during surgery to avoid the need for follow-up surgeries.

1 Jun 2017

New PET radiotracer can quickly, non-invasively detect life-threatening atherosclerotic plaques

In the featured article of the March 2017 issue of "The Journal of Nuclear Medicine," researchers demonstrate that a new positron emission tomography radiotracer, gallium-68 (Ga-68)-pentixafor, can quickly and non-invasively identify life-threatening atherosclerotic plaques.

1 Mar 2017

Novel imaging agent can rapidly and accurately detect metastasis of prostate cancer

New research demonstrates that a novel imaging agent can quickly and accurately detect metastasis of prostate cancer, even in areas where detection has previously been difficult.

2 Dec 2016